AGGRENOX 25mg / 200mg modified release capsules medication leaflet

B01AC30 acetylsalicylic acid + dipyridamole • Blood and blood forming organs | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin

Acetylsalicylic acid + dipyridamole is a combination medication primarily used for the prevention of ischemic strokes in patients who have already experienced such an event or are at high risk. This combination works by preventing blood clot formation and improving blood flow to the brain.

Acetylsalicylic acid acts as an antiplatelet agent, reducing the ability of platelets to form clots, while dipyridamole enhances its effect by inhibiting adenosine uptake, leading to blood vessel dilation and a reduced risk of thrombosis.

Side effects may include headaches, dizziness, gastric irritation, nausea, or an increased risk of bleeding. It is important for patients to follow their doctor’s instructions and inform the specialist about any pre-existing conditions or medications, as this combination may interact with other treatments.

General data about AGGRENOX 25mg / 200mg

Substance: acetylsalicylic acid + dipyridamole

Date of last drug list: 01-08-2018

Commercial code: W59803002

Concentration: 25mg / 200mg

Pharmaceutical form: modified release capsules

Quantity: 60

Product type: original

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.